Pittenger & Anderson »

Karyopharm Therapeutics shares owned by Pittenger & Anderson

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Pittenger & Anderson from 13F filings

Historical chart of Pittenger & Anderson investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Pittenger & Anderson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Pittenger & Anderson

Quarter filed Position value Share count Share price at filing
2025-09-30 $20 3 6.67

More positions owned by Pittenger & Anderson

Fiserv (FI)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Costco Wholesale Corporation (COST)
Amazon (AMZN)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Visa Com Cl A (V)

View all positions for Pittenger & Anderson

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Adage Capital Partners GP
Vanguard Group
Susquehanna International
BlackRock
Affinity Asset Advisors
Catalio Capital Management
Avidity Partners Management
Marshall Wace
CAM Group Holding A/S
Geode Capital Management
Citadel Advisors
Group One Trading
Renaissance Technologies
UBS Group

View all funds holding Karyopharm Therapeutics